Biofrontera AG : Biofrontera AG appoints M.M.Warburg & CO as new Designated Sponsor
(Thomson Reuters ONE) -
Biofrontera AG /
Biofrontera AG : Biofrontera AG appoints M.M.Warburg & CO as new Designated
Sponsor
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Leverkusen, Germany - Biofrontera AG (DSE: B8F) has, effective August 1, 2013,
appointed M.M.Warburg & CO as new Designated Sponsor.
Established in Hamburg in 1798, M.M.Warburg & CO is now one of the largest
private banks in Germany. The Department of Designated sponsoring currently
works with over 25 companies. It is regularly awarded an A/A-rating by the
Deutsche Börse. With subsidiary banks and holding companies, the Warburg bank
group is represented in many locations in Germany and neighbouring countries.
As Designated Sponsor, M.M.Warburg & CO will provide liquidity to the ongoing
trading of the company's shares on the XETRA system through binding bid and
offer quotes. In addition, M.M.Warburg & CO will prepare research on Biofrontera
and assist the company in its efforts to reach out to investors, in Germany and
overseas.
"M.M.Warburg & CO's expertise and its international network makes it an ideal
partner as Designated Sponsor for an internationally expanding company such as
Biofrontera. Appointing Thomas Schaffer as new CFO and now mandating M.M.Warburg
& CO are consequent steps towards growing and further internationalizing
Biofrontera group," explained Prof. Hermann Lübbert, CEO of Biofrontera AG.
Biofrontera AG
Biofrontera aims at attending and treating the skin, recognizing the aesthetic
needs of a person's visual reflection.
Biofrontera AG is listed on the regulated market of the Frankfurt stock exchange
under the symbol B8F and the ISIN number DE0006046113.
www.biofrontera.com
This press release contains forward-looking statements based on the currently
held beliefs and assumptions of the management of Biofrontera AG, which are
expressed in good faith and, in their opinion, reasonable. Forward-looking
statements involve known and unknown risks, uncertainties and other factors,
which may cause the assumptions expressed or implied in this press release to be
faulty. Given these risks, uncertainties and other factors, recipients of this
document are cautioned not to place undue reliance on the forward-looking
statements. Biofrontera AG disclaims any obligation to update these forward-
looking statements to reflect future events or developments.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biofrontera AG via Thomson Reuters ONE
[HUG#1720548]
Unternehmensinformation / Kurzprofil:
Datum: 01.08.2013 - 15:09 Uhr
Sprache: Deutsch
News-ID 283992
Anzahl Zeichen: 3289
contact information:
Town:
Leverkusen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biofrontera AG : Biofrontera AG appoints M.M.Warburg & CO as new Designated Sponsor"
steht unter der journalistisch-redaktionellen Verantwortung von
Biofrontera AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
